Latest Breaking News On - கோட்டை கட்டம் - Page 1 : vimarsana.com
Imara Announces Opening of Higher Dose Arms in Global Phase 2b Clinical Trials of IMR-687 for Sickle Cell Disease and Beta-Thalassemia
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Imara reports Phase 2a clinical trial results of -2-
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
(2)
DJ Imara reports Phase 2a clinical trial results of IMR-687 in adult patients with sickle cell disease
Arix Bioscience PLC (ARIX)
Imara reports Phase 2a clinical trial results of IMR-687 in adult patients
with sickle cell disease
06-Jan-2021 / 14:00 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement. Arix Bioscience plc Imara reports Phase 2a clinical trial results of IMR-687 in adult patients with sickle cell disease LONDON, 06 January 2021: Arix Bioscience plc ( Arix , LSE: ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, notes that its portfolio company, Imara Inc. (Nasdaq: